Darnell Cooper v. William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc.

CourtDistrict Court, C.D. Illinois
DecidedJanuary 30, 2026
Docket4:24-cv-04031
StatusUnknown

This text of Darnell Cooper v. William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc. (Darnell Cooper v. William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Darnell Cooper v. William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc., (C.D. Ill. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF ILLINOIS ROCK ISLAND DIVISION

DARNELL COOPER, Plaintiff,

v. Case No. 4:24-cv-04031-JEH

WILLIAM BOND, et al., Defendants.

Order This matter is now before the Court on the parties’ Motions for Summary Judgment under Federal Rule of Civil Procedure 56 and Local Rule 7.1(D)(1). (Docs. 109, 116, 118). For the reasons stated below, Plaintiff’s Motion for Summary Judgment is DENIED, and Defendants’ Motions for Summary Judgment are GRANTED. I On August 20, 2024, Plaintiff Darnell Cooper, proceeding pro se, filed an Amended Complaint under 42 U.S.C. § 1983 alleging that Defendants William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc. (“Wexford”) were deliberately indifferent to his dry eye condition in violation of the Eighth Amendment while he was incarcerated at Hill Correctional Center (“Hill”). (Docs. 45, 53). Plaintiff filed a Motion for Summary Judgment (Doc. 109); Defendants filed Responses (Docs. 119, 126); and Plaintiff filed Replies (Doc. 129, 137). Defendants Carter, Osmundson, and Wexford (the “Wexford Defendants”) filed a Motion for Summary Judgment (Doc. 116); Plaintiff filed a Response (Doc. 127); and the Wexford Defendants filed a Reply (Doc. 139). Defendant Bond filed a Motion for Summary Judgment (Doc. 118); Plaintiff filed a Response (Doc. 128); and Defendant Bond filed a Reply (Doc. 133). II The Court finds the following material facts. During the relevant period between September 2022 and December 2023, Plaintiff was an inmate in the custody of the Illinois Department of Corrections (“IDOC”) and incarcerated at Hill. Defendant Dr. Kurt Osmundson was the Medical Director at Hill. (Doc. 116- 1 at ¶ 3). Defendant Dr. Anthony Carter, a board-certified optometrist, provided optometry care to inmates at Hill. (Doc. 116-2 at ¶¶ 2-3). Defendants Osmundson and Carter were not responsible for receiving and handling inmates’ sick call requests or grievances. (Doc. 116-1 at ¶ 5; Doc. 116-2 at ¶ 5). After entering medical orders, Defendants Osmundson and Carter relied on the nurses and prison staff to execute their orders, provide prescribed medication to inmates, maintain medication administration records, and schedule appointments. (Doc. 116-1 at ¶¶ 6-7; Doc. 116-2 at ¶¶ 6-7). Defendant Dr. William Bond, a physician licensed to practice in the State of Illinois, performed private ophthalmological medical work at Bond Eye Associates, S.C. in Peoria and Pekin, Illinois. (Doc. 118 at pp. 140-141, ¶¶ 2, 8). Defendant Bond was not an employee, officer, agent, or apparent agent of Wexford or its subsidiaries, Hill, the IDOC, the State of Illinois, or any other government entity, nor did any such entity have the authority to direct or control his work as an ophthalmologist. Id. at ¶¶ 3, 5. Defendant Bond did not maintain a contractual relationship with Wexford to provide medical services to IDOC inmates. Id. at ¶¶ 4, 6. However, Bond Eye Associates had a contractual agreement with Wexford to provide optometry care to IDOC inmates. (Doc. 109 at pp. 68-70). Prior to the relevant period, Plaintiff was diagnosed with dry eye syndrome and provided with lower punctual plugs in his left and right eyes. (Doc. 116-17 at p. 2). Punctual plugs are used to block the drainage of tears to help lubricate dry eyes. (Doc. 116-2 at ¶ 9). On April 12, 2022, Defendant Carter saw Plaintiff for an eye examination and was unable to observe the lower left punctual plug. Concerned that the plug fell out, Defendant Carter ordered that Plaintiff be referred to an outside specialist. (Doc. 116-2 at ¶ 11; Doc. 116-9 at p. 33). On April 14, 2022, Defendant Osmundson approved the referral order. (Doc. 116-1 at ¶ 8). Defendants Carter, Osmundson, and Bond were not involved in the scheduling process. Id.; Doc. 116-2 at ¶ 12; Doc. 118 at p. 145, ¶ 19. On September 7, 2022, Plaintiff was examined by Defendant Bond at Bond Eye Associates. Id. at p. 141, ¶ 9. Plaintiff presented with dry eye syndrome, allergies, and blepharitis in both eyes. Id. Plaintiff’s vision was in the 20/30 to 20/40-2 range. Id. at pp. 152-158. Defendant Bond recommended a topical antihistamine and cool compresses/rinses and prescribed Maxitrol drops to treat Plaintiff’s allergies and blepharitis. Id. Defendant Bond believed punctual plugs might be appropriate but wanted to see if Plaintiff’s symptoms improved with the Maxitrol drops. Id. at pp. 141-142, ¶ 9c. When Plaintiff returned to Hill, Defendant Osmundson attended a follow- up with Plaintiff and entered an order for the Maxitrol drops Defendant Bond prescribed. (Doc. 116-1 at ¶ 9; Doc. 116-4 at p. 6; Doc. 116-7 at p. 52). Defendant Bond had no authority or control over Plaintiff’s access to or use of the medications he prescribed. (Doc. 118 at p. 144, ¶ 18a). On September 13, 2022, Defendant Carter performed a review of Plaintiff’s chart and noted Plaintiff saw Defendant Bond on September 7, 2022, and that Defendant Osmundson ordered the Maxitrol drops. (Doc. 116-2 at ¶ 13; Doc. 116- 4 at p. 6; Doc. 116-7 at p. 53). According to Defendants Carter and Osmundson, they were not made aware of any issue with Plaintiff receiving the Maxitrol drops between September 7, 2022 and October 4, 2022. (Docs. 116-1 at ¶ 10; Doc. 116-2 at ¶ 14). On October 4, 2022, Plaintiff saw Defendant Bond for a follow-up appointment. (Doc. 118 at p. 142, ¶ 10). Plaintiff reported he never received the Maxitrol drops and artificial tears. Id. at p. 160. Plaintiff also reported an increase in eye blurriness and dryness, as well as some pain and discomfort in the mornings due to dryness. Id. Based on his evaluation and Plaintiff’s worsening symptoms, Defendant Bond suggested punctual occlusion to relieve Plaintiff’s dry eye symptoms. Id. at p. 142, ¶ 10a; pp. 159-163. Based on Defendant Bond’s education, experience, and training as an ophthalmologist, he believed the presence of allergies would not hinder the effectiveness of the plugs or cause adverse effects, such as pain or worsening vision. Id. at p. 142, ¶ 10d. Defendant Bond placed a bilateral upper permanent punctual plug in each eye. Id. at ¶ 10c. Plaintiff claims he did not provide consent to have the punctual plugs placed in his eyes while the infection was still present. (Doc. 128 at p. 30, ¶ 49). Defendant Bond instructed Plaintiff to use Maxitrol and artificial tears. (Doc. 118 at p. 142, ¶ 10c; p. 163). According to Defendant Carter, he was not informed of, nor consulted with regarding, Defendant Bond’s treatment decisions, including placement of the upper punctual plugs. (Doc. 116-2 at ¶ 15). Upon Plaintiff’s return to Hill, Defendant Carter and another practitioner approved and entered the order for Maxitrol. (Doc. 116-4 at p. 6; Doc. 116-7 at pp. 55-56). Plaintiff received the Maxitrol drops as prescribed. (Doc. 116-16 at pp. 24-25). On October 18, 2022, Defendant Carter performed a review of Plaintiff’s chart and noted Plaintiff was using Maxitrol and scheduled for further follow-up with Defendant Bond. (Doc. 116-2 at ¶ 16; Doc. 116-7 at p. 57). On October 20, 2022, Defendant Osmundson reviewed and approved an order for a follow-up examination with Defendant Bond. (Doc. 116-1 at ¶ 11; Doc. 116-7 at p. 58). During an appointment with Defendant Bond on October 31, 2022, Plaintiff complained of bilateral eye pain and swelling in his left eye. Plaintiff stated he stopped using Maxitrol because it caused more irritation. Upon examination, Defendant Bond noted Plaintiff had improvement in the tear film, which indicated improvement of Plaintiff’s dry eye syndrome. Defendant Bond concluded Plaintiff might be allergic to Maxitrol and prescribed Tobradex. (Doc. 118 at pp. 142-143, ¶ 11; pp. 164-167).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Thomas v. Cook County Sheriff's Department
604 F.3d 293 (Seventh Circuit, 2010)
Roe v. Elyea
631 F.3d 843 (Seventh Circuit, 2011)
Cornel J. Rosario v. Daniel R. Braw
670 F.3d 816 (Seventh Circuit, 2012)
Sandra L. Waldridge v. American Hoechst Corp.
24 F.3d 918 (Seventh Circuit, 1994)
Curtis J. Celske v. Thomas Edwards
164 F.3d 396 (Seventh Circuit, 1999)
Orrin S. Reed v. Daniel McBride
178 F.3d 849 (Seventh Circuit, 1999)
Donald McCormick v. City of Chicago
230 F.3d 319 (Seventh Circuit, 2000)
Eric Michael v. St. Joseph County
259 F.3d 842 (Seventh Circuit, 2001)
Armond Norfleet v. Thomas Webster and Alejandro Hadded
439 F.3d 392 (Seventh Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Darnell Cooper v. William Bond, Anthony Carter, Kurt Osmundson, and Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/darnell-cooper-v-william-bond-anthony-carter-kurt-osmundson-and-wexford-ilcd-2026.